Delivery Order SPE2DR25D2205-SPE2DR26F2A69
Award Date 2/9/26
Potential Completion Date 2/10/26
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Actemra Actpen 162 mg/0.9 ml auto-injector pharmaceutical product, with a ceiling value of $15,620.70.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of February 9, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $58,983.31 for supply of Actemra 162 mg/0.9 mL syringes. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Actemra 162 mg/0.9 ml syringes with a ceiling value of $12,043.64. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract valued at up to $999,999,999.00 through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order...
- The Defense Logistics Agency awarded a delivery order valued at $31,344.83 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL auto-injectors. This firm fixed-price delivery order, issued on February 3, 2026, with an ultimate completion date of February 4, 2026, represents a non-competitive procurement leveraging an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Actemra ActPen (162 mg/0.9 mL) auto-injectors. This firm fixed price delivery order carries a ceiling value of $3,066.26 and is scheduled for completion by August 19, 2025. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $14,309.38 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector pens on February 2, 2026, with a completion date of February 3, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order for pharmaceutical products to support federal medical procurement needs. The order will be fulfilled from the vendor's corporate...
- The Defense Logistics Agency awarded a $19,985.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injectors. The order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector pens, with a ceiling value of $1,259.18. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order is set for ultimate completion by November 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,720.54 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This firm fixed-price delivery order, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,003.48 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL auto-injectors. This firm fixed-price delivery order is scheduled for completion by January 15, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's larger...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F2A69Delivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $25,485.10 for supply of Actemra Actpen 162 mg/0.9 mL auto-injector units. Place of performance is Conshohocken, PA 19428. The order matures February 10, 2026. This is a firm fixed-price delivery order issued under no set-aside. The parent vehicle is the DLA Troop Support Medical indefinite delivery contract held by Cencora, Inc. (parent of the awardee), valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities globally to support military healthcare programs.
Generated 5/10/26, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.5k | 2/8/26 |